Literature DB >> 19369675

Risks of long-acting beta-agonists in achieving asthma control.

Jeffrey M Drazen, Paul M O'Byrne.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19369675     DOI： 10.1056/NEJMe0902057

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

Review 1.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

2.  Tiotropium bromide step-up therapy for adults with uncontrolled asthma.

Authors:  Stephen P Peters; Susan J Kunselman; Nikolina Icitovic; Wendy C Moore; Rodolfo Pascual; Bill T Ameredes; Homer A Boushey; William J Calhoun; Mario Castro; Reuben M Cherniack; Timothy Craig; Loren Denlinger; Linda L Engle; Emily A DiMango; John V Fahy; Elliot Israel; Nizar Jarjour; Shamsah D Kazani; Monica Kraft; Stephen C Lazarus; Robert F Lemanske; Njira Lugogo; Richard J Martin; Deborah A Meyers; Joe Ramsdell; Christine A Sorkness; E Rand Sutherland; Stanley J Szefler; Stephen I Wasserman; Michael J Walter; Michael E Wechsler; Vernon M Chinchilli; Eugene R Bleecker
Journal:  N Engl J Med       Date:  2010-09-19       Impact factor: 91.245

3.  Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies.

Authors:  Shoroq M Altawalbeh; Carolyn T Thorpe; Janice C Zgibor; Sandra Kane-Gill; Yihuang Kang; Joshua M Thorpe
Journal:  J Am Geriatr Soc       Date:  2016-06-28       Impact factor: 5.562

4.  Prevalence, incidence and persistence of anti-asthma medication use in 2- to 29-year-olds: a nationwide prescription study.

Authors:  Oystein Karlstad; Per Nafstad; Aage Tverdal; Svetlana Skurtveit; Kari Furu
Journal:  Eur J Clin Pharmacol       Date:  2009-11-21       Impact factor: 2.953

5.  Safety of long-acting beta2-agonists in the management of asthma: a Primary Care Respiratory Alliance of Canada perspective.

Authors:  Anthony D D'Urzo; Pieter Jugovic; Jacques Bouchard; Reuven Jhirad; Itamar Tamari
Journal:  Can Fam Physician       Date:  2010-02       Impact factor: 3.275

Review 6.  Anticholinergics/antimuscarinic drugs in asthma.

Authors:  Xavier Soler; Joe Ramsdell
Journal:  Curr Allergy Asthma Rep       Date:  2014-12       Impact factor: 4.806

7.  β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis.

Authors:  Sergio E Chiarella; Saul Soberanes; Daniela Urich; Luisa Morales-Nebreda; Recep Nigdelioglu; David Green; James B Young; Angel Gonzalez; Carmen Rosario; Alexander V Misharin; Andrew J Ghio; Richard G Wunderink; Helen K Donnelly; Kathryn A Radigan; Harris Perlman; Navdeep S Chandel; G R Scott Budinger; Gökhan M Mutlu
Journal:  J Clin Invest       Date:  2014-05-27       Impact factor: 14.808

Review 8.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

Review 9.  Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Authors:  Donald P Tashkin; Leonardo M Fabbri
Journal:  Respir Res       Date:  2010-10-29

Review 10.  Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism.

Authors:  Nicola A Hanania; Burton F Dickey; Richard A Bond
Journal:  Curr Opin Pulm Med       Date:  2010-01       Impact factor: 3.155
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.